Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,137
Total Claims
$1.9M
Drug Cost
1,369
Beneficiaries
$1,365
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-93%
Opioid rate vs peers
0.2% vs 2.6% avg
+28%
Cost per patient vs peers
$1,365 vs $1,068 avg
+46%
Brand preference vs peers
13.1% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
32
Opioid Claims
$547
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,350 claims · $1.5M
Generic: 15,555 claims · $329K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 170 | $212K |
| Apixaban | 258 | $196K |
| Dulaglutide | 110 | $125K |
| Rivaroxaban | 87 | $73K |
| Linagliptin | 73 | $65K |
| Empagliflozin | 73 | $61K |
| Fluticasone/Umeclidin/Vilanter | 68 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 96 | $57K |
| Mirabegron | 79 | $51K |
| Insulin Degludec | 12 | $32K |
| Insulin Aspart | 25 | $32K |
| Sitagliptin Phosphate | 28 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 35 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $27K |
| Insulin Aspart Prot/Insuln Asp | 26 | $22K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data